Editorially independent content supported by Amaros, Atia Vision, Aurion Biotech, Azura Ophthalmics, EyeYon Medical, Iantrek, PLU Ophthalmic, SpyGlass Pharma, Tenpoint Therapeutics, and ViaLase.
Visionary Breakthroughs
A Spotlight on Innovations in Eye Care
Among medical specialties, ophthalmology has always enjoyed a rapid pace of innovation. Across its subspecialties, the field continues to deliver transformative breakthroughs, driven by a diverse range of technological advancements including lasers, wavefront analysis, microincisional techniques, high-resolution imaging, implantable devices, adaptive optics, biocompatible materials, and pharmaceutical developments.
Now, as artificial intelligence (AI) introduces unprecedented computational capabilities into research and development, the momentum behind ophthalmic innovation is poised to accelerate further—broadening both its scope and its impact on future patient care.
Bryn Mawr Communications—the publisher of Cataract & Refractive Surgery Today, Glaucoma Today, and Eyetube, among other leading platforms—presents this special supplement to spotlight some of the most exciting developments redefining the future of ophthalmology. What follows is an overview of innovations that are reshaping the way clinicians will diagnose, treat, and care for patients.


Dive Deeper: Video interviews with these visionary companies will be posted to EyewireTV.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Visionary Breakthroughs
Corneal Endothelial Cell Therapy
Arnaud Lacoste, MBA, PhD, CEO and Chief Scientific Officer; Eris P. Jordan, OD, Chief Development Officer, Aurion BiotechArnaud Lacoste, MBA, PhD, CEO and Chief Scientific Officer; Eris P. Jordan, OD, Chief Development Officer, Aurion Biotech



